期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
原发性开角型青光眼视野损害进展相关因素的随访研究 被引量:5
1
作者 耿文慧 王大博 韩静 《国际眼科杂志》 CAS 北大核心 2020年第10期1814-1818,共5页
目的:探究原发性开角型青光眼(POAG)患者视野损害进展的相关因素,为临床POAG患者更准确高效的随访提供思路。方法:前瞻性病例系列研究。将POAG患者39例77眼纳入随访研究,详细询问病史后,进行眼内压(IOP)测量,视野检查及神经纤维层(RNFL... 目的:探究原发性开角型青光眼(POAG)患者视野损害进展的相关因素,为临床POAG患者更准确高效的随访提供思路。方法:前瞻性病例系列研究。将POAG患者39例77眼纳入随访研究,详细询问病史后,进行眼内压(IOP)测量,视野检查及神经纤维层(RNFL)厚度测量,每3mo 1次,共连续随访7次。对患者的家族史、吸烟及饮酒史、年龄、性别、是否手术、IOP波动、基线视野缺损程度、随访期间RNFL厚度变化与视野损害进展进行相关性分析。结果:随访期间RNFL厚度变化程度与视野损害进展呈正相关(P<0.05)。基线视野缺损程度与视野损害进展有关,中度基线视野缺损与视野损害进展相关性最大,轻度次之,重度最小。结论:RNFL的厚度变化可能为POAG患者进展性随访提供有用信息;轻度和重度视野缺损患者进展性的判断应结合视野外信息。 展开更多
关键词 原发性开角型青光眼 Octopus视野计 视网膜神经纤维层厚度 基线视野缺损
下载PDF
Efficacy and safety of intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy compared with Ahmed glaucoma valve implantation in neovascular glaucoma 被引量:14
2
作者 Jin-Tao Sun Hai-Jing Liang +1 位作者 Meng An da-bo wang 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2017年第3期400-405,共6页
AIM:To evaluate the efficacy and safety of intravitreal ranibizumab(IVR)with panretinal photocoagulation(PRP)followed by trabeculectomy compared with Ahmed glaucoma valve(AGV)implantation in neovascular glaucom... AIM:To evaluate the efficacy and safety of intravitreal ranibizumab(IVR)with panretinal photocoagulation(PRP)followed by trabeculectomy compared with Ahmed glaucoma valve(AGV)implantation in neovascular glaucoma(NVG).METHODS:This was a retrospective comparative study.We reviewed the cases of a total of 45 eyes from 45 NVG patients among which 23 eyes underwent AGV implantation and the other 22 underwent trabeculectomy. The causes of neovascular glaucoma included:diabetic retinopathy(25 eyes),and retinal vein occlusion(20 eyes).All patients received preoperative IVR combined with postoperative PRP. The mean best-corrected visual acuities(BCVA)were converted to the logarithms of the minimum angle of resolution(log MAR)for the statisitical analyses.Intraocular pressure(IOP),the log MAR BCVA and surgical complications were evaluated before and after surgery.The follow-up period was 12 mo.RESULTS:A total of 39 cases showed complete regression of iris neovascularization at 7d after injection,and 6 cases showed a small amount of residual iris neovascularization. The success rates were 81.8% and 82.6% at 12 mo after trabeculectomy and AGV implantation,respectively. In the trabeculectomy group,the log MAR BCVA improved at the last follow-up in 14 eyes,remained stable in 6 eyes and decreased in 2 eyes. In 4 cases,slight hyphemas developed after trabeculectomy. A shallow anterior chamber developed in 2 cases and 2 vitreous hemorrhages. In the AGV group,the log MAR BCVA improved in 14 eyes,remained stable in 5 eyes and decreased in 4 eyes. Slight hyphemas developed in 3 cases,and a shallow anterior chamber in 3 cases. The mean postoperative IOP was significantly lower in both groups after surgery(F=545.468,P〈0.05),and the mean postoperative log MAR BCVA was also significantly improved(F=10.964,P〈0.05)with no significant difference between two groups.CONCLUSION:It is safe and effective to treat NVG with this combined procedure,and we found similar results after IVR+AGV implantation+PRP and IVR+trabeculectomy+PRP in eyes with NVG. 展开更多
关键词 neovascular glaucoma trabeculectomy Ahmed drainage valve implantation ranibizumab panretinal photocoagulation
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部